On Halloween, Lexicon was haunted again as an FDA advisory committee voted 11-3 to reject Zynquista as an accompanying ...

An FDA advisory committee voted Thursday that it didn’t believe the benefits of Lexicon's (LXRX) diabetes drug sotagliflozin ...

The battlelines are revealed by OCTA Research, which reports as of September (all figures in percent) the following: “Pro-Marcos,” 38; “Pro-Duterte,” 15; and “Pro-Opposition” 7 (apparently meaning the ...

Jeremy Strong attends 'The Apprentice" NY premiere at the DGA theatre in New York, October 8, 2024 CREDIT: Angela Weiss / AFP via Getty Images Jeremy Strong has admitted that working on Succession ...

Viatris is ponying up $25 million upfront to obtain the rights to sell Lexicon Pharmaceuticals ... Inpefa is part of a strong class of SGLT2 inhibitors that also includes Boehringer Ingelheim ...

THE WOODLANDS, Texas, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals ... a company with strong cardiometabolic expertise, global commercial capabilities and a successful track record ...

Cecily Strong revealed she is pregnant with a personal message ahead of Tuesday’s general election. Wearing a “pregnant, pro-choice and proud” shirt, the “Saturday Night Live” alum ...

Actor Jeremy Strong, best known for playing troubled media heir Kendall Roy in TV’s Succession, has told NME that he’s definitely on the cast for upcoming Bruce Springsteen biopic Deliver Me ...

To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Lexicon Pharmaceuticals is selling rights to its only marketed drug outside of the U.S. and Europe amid a ...

Help us keep bring these critical stories to light. Your support makes all the difference. Mark Strong has said it’s a “shame” that actors are no longer “allowed” to portray characters ...

Lexicon CEO and Director, Dr. Mike Eaton, Ph.D., said: "We are pleased to be working with Viatris, a company with strong cardiometabolic expertise, global commercial capabilities and a successful ...

PITTSBURGH, Oct. 16, 2024 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it has entered into an exclusive licensing agreement with Lexicon ...